Market Place
Sourcing Support
EMA Grants GMP Certificate to CuraTeQ Biosimilars Facility
12 Nov 2024 //
FINANCIALXPRESS
Aurobindo Pharma Net Profit Up 7.95% in Sept. 2024 Quarter
11 Nov 2024 //
BUSINESS STD
Aurobindo Pharma Ltd drops for fifth straight session
11 Nov 2024 //
BUSINESS STD
FDA Issues Form 483 to Apitoria Pharma Private Ltd.
07 Oct 2024 //
FDA
U.S. FDA issues 10 observations to Aurobindo arm`s API unit
01 Oct 2024 //
THE HINDU
PM Modi To Inaugurate Penicillin-G Plant In Andhra Pradesh
22 Sep 2024 //
ECONOMIC TIMES
Aurobindo to acquire 49 pc stake in GLS Pharma for Rs 22.5 cr
20 Sep 2024 //
ECONOMICTIMES
Briefs: Medicamen Biotech, Aurobindo Pharma and Ajooni Biotech
11 Sep 2024 //
INDIANPHARMAPOST
Aurobindo, Glenmark, FDC Recall US Products Over Manufacturing Issues
26 Aug 2024 //
ECONOMICTIMES
USFDA pulls up Eugia for manufacturing lapses, data accuracy at Hyderabad plant
26 Aug 2024 //
ECONOMICTIMES
Aurobindo Pharma to commercialise China plant in third quarter of FY25: CFO
19 Aug 2024 //
ECONOMICTIMES
Aurobindo Pharma stock tanks 6% after unit gets warning letter from USFDA
16 Aug 2024 //
BUSINESS STANDARD
Aurobindo Pharma`s Eugia Unit-3 gets warning letter from USFDA, shares fall
16 Aug 2024 //
ECONOMICTIMES
Aurobindo may take its injectable unit public
14 Aug 2024 //
ECONOMICTIMES
Aurobindo Pharma Q1 net profit jumps 61 pc at Rs 919 cr
11 Aug 2024 //
ECONOMICTIMES
Aurobindo gets USFDA nod for generic version of Novo Nordisk`s Vagifem
07 Aug 2024 //
ECONOMICTIMES
FDA Issues `Official Action Indicated` For Aurobindo`s Eugia Unit
06 Aug 2024 //
BSEINDIA
Aurobindo Pharma`s Generics Estradiol Receives Approval in US
02 Aug 2024 //
FDA
Aurobindo Pharma’s subsidiary acquires Ace Laboratories, UK
29 Jun 2024 //
INDIANPHARMAPOST
Aurobindo Pharma`s Generic Lidocaine Receives Approval in US
18 Jun 2024 //
FDA
Aurobindo `s Generic Betamethasone Dipropionate Receives Approval in the U.S
04 Jun 2024 //
FDA
Aurobindo Pharma net zooms by 79% in Q4 to Rs. 907 crore
28 May 2024 //
PHARMABIZ
Enforcement Report - Week of May 15, 2024
15 May 2024 //
FDA
Under FDA scrutiny, Aurobindo`s Eugia tallies a 5th Form 483 in less than a year
14 May 2024 //
FIERCE PHARMA
An Indian industrialist wants to buy Biogaran, the French number one in generics
18 Apr 2024 //
20MINUTES
Aurobindo Pharma`s Generic Ibuprofen Receives Approval in the U.S.
08 Apr 2024 //
FDA
Aurobindo arm gets 3 observations from US FDA after Andhra unit inspection
08 Apr 2024 //
MONEYCONTROL
Aurobindo commissions 4 plants in AP including Pen-G and 6-APA facilities
01 Apr 2024 //
INDINPHARMAPOST
Aurobindo arm extends negotiations deadline with MSD for CMO operations
28 Mar 2024 //
ECONOMIC TIMES
Aurobindo receives USFDA approval for Mometasone Furoate Monohydrate nasal spray
20 Mar 2024 //
INDIANPHARMAPOST
After a pause, Aurobindo resumes drug shipments from India plant
13 Mar 2024 //
FIERCE PHARMA
Aurobindo Pharma`s Generic Mycophenolic Sodium Receives Approval in the U.S.
27 Feb 2024 //
FDA
Aurobindo Pharma`s Generic Deflazacort Receives Approval in the U.S.
09 Feb 2024 //
FDA
Aurobindo Pharma`s Generic Lacosamide Receives Approval in the U.S.
24 Jan 2024 //
FDA
Aurobindo Pharma gets USFDA nod for generic antifungal injection
27 Dec 2023 //
ECONOMIC TIMES
USFDA inspects Aurobindo Pharma`s New Jersey-based facility, issues 10 observations
24 Dec 2023 //
MONEY CONTROL
FDA classifies Aurobindo plant as needing `voluntary` action
20 Dec 2023 //
FIERCE PHARMA
Aurobindo Pharma gets USFDA nod for HIV drug
29 Nov 2023 //
ECONOMIC TIMES
Aurobindo Pharma`s Generic Darunavir Receives Approval in the U.S.
28 Nov 2023 //
FDA
Aurobindo eyes ‘WuXi’ moment to kickstart Indian bio-CDMO sector
20 Nov 2023 //
BIO PROCESS INTERNATIONAL
Aurobindo Pharma posts Q2 FY 24 up 84% at Rs. 752 Cr
10 Nov 2023 //
INDIAN PHARMA POST
Aurobindo Pharma completes sale of Antibiotic business to Apitoria Pharma
03 Oct 2023 //
INDIAN PHARMA POST
Enforcement Report - Week of September 27, 2023
27 Sep 2023 //
FDA
Aurobindo Pharma`s Generic Deutetrabenazine Receives Approval in the U.S.
26 Sep 2023 //
FDA
Aurobindo`s Andhra plant receives 1 observation from USFDA after inspection
20 Sep 2023 //
ECONOMIC TIMES
Aurobindo puts its injectables business on the block, again
24 Aug 2023 //
ECONO MIC TIMES
Alembic, Aurobindo Pharma issue separate US drug recalls
21 Aug 2023 //
FIERCE PHARMA
Aurobindo`s Generic Fluphenazine Hydrochloride Receives Approval in the U.S.
18 Aug 2023 //
FDA
Aurobindo Pharma gets U.S. FDA nod for generic Icatibant injection
16 Aug 2023 //
THE HINDU
Aurobindo Pharma arm gets USFDA nod for Plerixafor injection
25 Jul 2023 //
ECONOMIC TIMES
Aurobindo’s Hyd unit gets 3 observations from USFDA
23 Jul 2023 //
TIMES OF INDIA
Aurobindo Pharma eyes $5-B revenue in 5 years
21 Jul 2023 //
ECONOMIC TIMES
Aurobindo`s Generic Darunavir Receives Approval in the U.S.
20 Jul 2023 //
FDA
Aurobindo`s Generic Hydrocortisone Receives Approval in the U.S.
17 Jul 2023 //
FDA
